Device / Technology News

RSS

SureGene selects PGXL as laboratory provider for STA2R genetic panel

SureGene has chosen PGXL as laboratory provider for its proprietary STA2R genetic panel, which promises to revolutionize the treatment of schizophrenia.

30 Aug 2012

Nipro Diagnostics, NextGen enter agreement for TRUEresult blood glucose monitoring system

NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with Nipro Diagnostics, Inc. to integrate its TRUEresult blood glucose monitoring system into the NextGen Ambulatory EHR.

30 Aug 2012

Carnegie Hill Radiology in New York installs Aquilion PRIME 160 series from Toshiba

Patients with irregular heartbeats (arrhythmia) are difficult to image with CT. Addressing this challenge, Carnegie Hill Radiology in New York installed the Aquilion PRIME 160 series from Toshiba America Medical Systems, Inc., featuring SURECardio Prospective software that automatically adjusts for irregular heartbeats, providing quicker, more accurate exams.

30 Aug 2012

New method simplifies pharmaceutical production of proteins

Engineering researchers at the University of Arkansas have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions, including diabetes, cancer, arthritis and macular degeneration.

29 Aug 2012

Anova Cancer Care to participate in CyberKnife research study

Anova Cancer Care has been chosen to participate in a landmark national prostate cancer study. The goal of the two-year study is to determine the best treatments for prostate cancer. The study will look specifically at prostate cancer radiosurgery.

29 Aug 2012

HealthPartners receives Acclaim Award from American Medical Group Association

The American Medical Group Association (AMGA) today announced that the recipient of the 2012 AMGA Acclaim Award is HealthPartners for "Triple Aim 2.0: Designing Culture to Support Better Health, Better Experience at a Lower Cost," an inventive and patient-centered approach to align the Institute of Medicine's Aims to identify and drive performance improvement, innovation, and culture throughout the organization.

29 Aug 2012

New treatment for severe dry eye is now available at U-M’s Kellogg

A new treatment available at the University of Michigan Kellogg Eye Center—prosthetic replacement of the ocular surface ecosystem or PROSE—provides relief to patients who suffer from severe dry eye, often the result of cancer or complex corneal disease.

29 Aug 2012

FISH assay identifies only few lung cancer patients who could benefit from crizotinib

Break apart a couple worm-like chromosomes and they may reconnect with mismatched tips and tails - such is the case of the EML4-ALK fusion gene that creates 2-7 percent of lung cancers. Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers. Informed doctors use the test called a FISH assay to check for the EML4-ALK fusion gene, and then if the test is positive, ALK+ patients benefit greatly from crizotinib.

29 Aug 2012

Novelos expects to submit CLR1502 IND with FDA for non-invasive tumor imaging

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.

29 Aug 2012

NYU-Poly creates ultra-sensitive biosensor to identify small single virus particles

Researchers at Polytechnic Institute of New York University (NYU-Poly) have created an ultra-sensitive biosensor capable of identifying the smallest single virus particles in solution, an advance that may revolutionize early disease detection in a point-of-care setting and shrink test result wait times from weeks to minutes.

29 Aug 2012

FFR-guided PCI plus medical therapy reduce need for urgent revascularization in CAD patients

Patients with stable coronary artery disease (CAD) had a lower need for urgent revascularisation when receiving fractional flow reserve (FFR)-guided PCI plus the best available medical therapy (MT) than when receiving MT alone. The results, from a final analysis of the FAME 2 trial, were presented today during a Hot Line session of ESC Congress 2012 in Munich.

29 Aug 2012

BMBF awards 16M€ to support German epigenome program initiative

The German Ministry for Research and Education (BMBF) will support the German epigenome program initiative "DEEP" with a budget of 16M€ over 5 years.

29 Aug 2012

Catheter ablation for Afib is safe and suppresses arrhythmia recurrences

Catheter ablation for atrial fibrillation (Afib) is safe and suppresses arrhythmia recurrences in 74% of patients after a single procedure, according to results from the one-year follow-up of the Atrial Fibrillation Ablation Pilot Study, the first European registry to evaluate the real-life epidemiology of catheter ablation for AFib.

29 Aug 2012

Ultra-fast 320-detector CT scanner can accurately diagnose arterial blockages

An ultra-fast, 320-detector computed tomography (CT) scanner can accurately sort out which people with chest pain need - or don't need - an invasive procedure such as cardiac angioplasty or bypass surgery to restore blood flow to the heart, according to an international study. Results of the study, which involved 381 patients at 16 hospitals in eight countries, are scheduled to be presented at the European Society of Cardiology Congress in Munich, Germany, on August 28.

29 Aug 2012

NUI Galway project hopes to deliver cost effective tool for rapid diagnosis of pneumonia

Researchers at NUI Galway are involved in a new European project which hopes to deliver a cost effective tool for the speedy diagnosis of infections such as pneumonia. The test would reduce diagnosis time from days to hours, so that the appropriate treatments can be administered as early as possible for the best possible outcome.

29 Aug 2012

DRG Diagnostics, BIT Analytical Instruments to launch new product

BIT Analytical Instruments, a complete contract product development, manufacturing services and after-sales service provider to medical and industrial instrument OEM clients, partnered with DRG Diagnostics to launch a revolutionary new product - the DRG:HYBRID XL Analyzer, a fully-automated and integrated random-access analyzer for immunoassays and clinical chemistry.

29 Aug 2012

Addition of CTP to CT angiography allows clinicians to identify flow-limiting coronary artery disease

A non-invasive imaging strategy which integrates non-invasive CT angiography (CTA) and CT myocardial perfusion imaging (CTP) has robust diagnostic accuracy for identifying patients with flow-limiting coronary artery disease in need of myocardial revascularisation, according to results of the CORE320 study presented here today by Dr Joao AC Lima from Johns Hopkins Hospital, Baltimore, USA.

29 Aug 2012

St. Jude’s EnligHTN renal denervation system safe and effective in treating resistant hypertension

St. Jude Medical, Inc., a global medical device company, today announced that interim data demonstrated the company's EnligHTN renal denervation system is safe and effective for the treatment of resistant hypertension.

29 Aug 2012

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

The FDA last month approved for use a small ingestible sensor that, when embedded into a pill, can help "keep track of whether a patient is taking their medicine on time," Reuters reports.

29 Aug 2012

SPR microscopy examines binding kinetics of membrane proteins

Proteins adorning the surfaces of human cells perform an array of essential functions, including cell signaling, communication and the transport of vital substances into and out of cells. They are critical targets for drug delivery and many proteins are now being identified as disease biomarkers - early warning beacons announcing the pre-symptomatic presence of cancers and other diseases.

29 Aug 2012

Device / Technology News

SureGene selects PGXL as laboratory provider for STA2R genetic panel

Nipro Diagnostics, NextGen enter agreement for TRUEresult blood glucose monitoring system

Carnegie Hill Radiology in New York installs Aquilion PRIME 160 series from Toshiba

New method simplifies pharmaceutical production of proteins

Anova Cancer Care to participate in CyberKnife research study

HealthPartners receives Acclaim Award from American Medical Group Association

New treatment for severe dry eye is now available at U-M’s Kellogg

FISH assay identifies only few lung cancer patients who could benefit from crizotinib

Novelos expects to submit CLR1502 IND with FDA for non-invasive tumor imaging

NYU-Poly creates ultra-sensitive biosensor to identify small single virus particles

FFR-guided PCI plus medical therapy reduce need for urgent revascularization in CAD patients

BMBF awards 16M€ to support German epigenome program initiative

Catheter ablation for Afib is safe and suppresses arrhythmia recurrences

Ultra-fast 320-detector CT scanner can accurately diagnose arterial blockages

NUI Galway project hopes to deliver cost effective tool for rapid diagnosis of pneumonia

DRG Diagnostics, BIT Analytical Instruments to launch new product

Addition of CTP to CT angiography allows clinicians to identify flow-limiting coronary artery disease

St. Jude’s EnligHTN renal denervation system safe and effective in treating resistant hypertension

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

SPR microscopy examines binding kinetics of membrane proteins

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News